File Download
There are no files associated with this item.
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: Propofol Ameliorates Hyperglycemia-induced Cardiac Hypertrophy and Dysfunction Via Heme Oxygenase-1 /STAT3 Signaling Pathway in Rats
Title | Propofol Ameliorates Hyperglycemia-induced Cardiac Hypertrophy and Dysfunction Via Heme Oxygenase-1 /STAT3 Signaling Pathway in Rats |
---|---|
Authors | |
Issue Date | 2014 |
Publisher | Lippincott, Williams & Wilkins. The Journal's web site is located at http://www.anesthesia-analgesia.org |
Citation | The 2014 Annual Meeting of the International Anesthesia Research Society (IARS 2014), Montréal, Canada, 17-20 May 2014. In Anesthesia and Analgesia, 2014, v. 118 n. 5S, p. S-77 How to Cite? |
Abstract | INSTRUCTION AND GENERAL PURPOSE OF THE
STUDY: Heme oxygenase-1 (HO-1) is inducible in cardiomyocytes
in response to stimuli like oxidative stress, and plays critical roles
in combating cardiac hypertrophy and injury1
.Signal transducer and
activator of transcription-3(STAT3) plays a pivotal role in HO-1
mediated protection against liver and lung injury under oxidative
stress2
. We hypothesized that propofol, an intravenous anesthetic
with antioxidant capacity that has been shown to induce HO-1
expression, may attenuate hyperglycemia-induced oxidative stress
in cardiomyocytes via enhancing HO-1 activation and ameliorate
hyperglycemia-induced cardiac hypertrophy and apoptosis via
HO-1 /STAT3 signaling, and improve cardiac function in diabetes.
METHODS: 8 weeks of streptozotocin-induced Type 1diabetic
rats received an i.v. injection of either saline or propofol at a
UDWH RI ȝJ NJ PLQ3
for 45 min. Cardiac function was assayed
by pressure-volume loop conduction system and free 15-F2tisoprostane
in plasma and heart tissue was detected by enzymelinked
immunoassay. Primary cultured neonatal rat cardiomyocytes
were exposed for 48 hours to either normal glucose (5.5mmol.L-1,
Control), a high concentration of glucose (HG, 25.5mmol.L-1) or
+*LQWKHSUHVHQFHRISURSRIRO
ȝPRO /
7RIXUWKHUFRQ¿UPWKH
UROHVRI+2 DQG67$7 SODHGLQWKHEHQH¿FLDOHIIHFWVRISURSRIRO
HO-1 or STAT3 genes expression was respectively knocked down
by siRNA in H9c2 cells. Cardiomyocyte cross-sectional area and
protein content were used as indices of hypertrophy. Reactive
R[JHQVSHFLHV
526
ZHUHGHWHFWHGE'+(ÀXRUHVFHQFHVWDLQLQJ
HO-1 and STAT3 protein expression were detected by Western blot.
Cardiomyocytes apoptosis were assessed by TUNEL assay.
RESULTS AND MAJOR FINDINGS: In Type-1 diabetic
UDWV PRFDUGLDO ) W LVRSURVWDQH ZDV VLJQL¿FDQWO LQFUHDVHG
accompanied with cardiomyocytes hypertrophy and impaired left
ventricular function that was coincident with reduced HO-1 activity
and STAT3 activation despite of an increase in HO-1 protein
H[SUHVVLRQDVFRPSDUHGWRFRQWURO 3URSRIROLQIXVLRQVLJQL¿FDQWO
improved cardiac function with concomitantly enhanced HO-1
activity and STAT3 activation. Similar to the changes seen in diabetic
rat hearts, high glucose exposure for 48 hours led to cardiomyocytes
hypertrophy and apoptosis in both the primarily cultured neonatal
rat cardiomyocyte and in H9c2 cells compared to normal glucose,
DFFRPSDQLHG E LQFUHDVHG 526 3URSRIRO VLJQL¿FDQWO LQFUHDVHG
cardiomyocyte HO-1 and p-STAT3 protein expression and HO-1
activity and attenuated HG-mediated cardiomyocyte hypertrophy
and apoptosis and reduced ROS production (P<0.05). These
protective effects of propofol were abolished by HO-1 or STAT3
gene knock down in H9c2 cells.
CONCLUSIONS: Activation of the HO-1/STAT3 signaling path
way is major mechanism whereby Propofol mediates amelioration
of hyperglycemia-induced cardiomyocyte hypertrophy and
apoptosis and cardiac dysfunction.
REFERENCES:
1 Circulation 2010;121:1912-25
2 J. of hepatology 2012;56:359-66)
3 BMC gastroenterology 2011;11:144 |
Description | Session: Cardiovascular Anesthesiology |
Persistent Identifier | http://hdl.handle.net/10722/204765 |
ISSN | 2023 Impact Factor: 4.6 2023 SCImago Journal Rankings: 1.344 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Xu, J | en_US |
dc.contributor.author | Li, H | en_US |
dc.contributor.author | Xia, Z | en_US |
dc.date.accessioned | 2014-09-20T00:39:19Z | - |
dc.date.available | 2014-09-20T00:39:19Z | - |
dc.date.issued | 2014 | en_US |
dc.identifier.citation | The 2014 Annual Meeting of the International Anesthesia Research Society (IARS 2014), Montréal, Canada, 17-20 May 2014. In Anesthesia and Analgesia, 2014, v. 118 n. 5S, p. S-77 | en_US |
dc.identifier.issn | 0003-2999 | - |
dc.identifier.uri | http://hdl.handle.net/10722/204765 | - |
dc.description | Session: Cardiovascular Anesthesiology | - |
dc.description.abstract | INSTRUCTION AND GENERAL PURPOSE OF THE STUDY: Heme oxygenase-1 (HO-1) is inducible in cardiomyocytes in response to stimuli like oxidative stress, and plays critical roles in combating cardiac hypertrophy and injury1 .Signal transducer and activator of transcription-3(STAT3) plays a pivotal role in HO-1 mediated protection against liver and lung injury under oxidative stress2 . We hypothesized that propofol, an intravenous anesthetic with antioxidant capacity that has been shown to induce HO-1 expression, may attenuate hyperglycemia-induced oxidative stress in cardiomyocytes via enhancing HO-1 activation and ameliorate hyperglycemia-induced cardiac hypertrophy and apoptosis via HO-1 /STAT3 signaling, and improve cardiac function in diabetes. METHODS: 8 weeks of streptozotocin-induced Type 1diabetic rats received an i.v. injection of either saline or propofol at a UDWH RI ȝJ NJ PLQ3 for 45 min. Cardiac function was assayed by pressure-volume loop conduction system and free 15-F2tisoprostane in plasma and heart tissue was detected by enzymelinked immunoassay. Primary cultured neonatal rat cardiomyocytes were exposed for 48 hours to either normal glucose (5.5mmol.L-1, Control), a high concentration of glucose (HG, 25.5mmol.L-1) or +*LQWKHSUHVHQFHRISURSRIRO ȝPRO / 7RIXUWKHUFRQ¿UPWKH UROHVRI+2 DQG67$7 SODHGLQWKHEHQH¿FLDOHIIHFWVRISURSRIRO HO-1 or STAT3 genes expression was respectively knocked down by siRNA in H9c2 cells. Cardiomyocyte cross-sectional area and protein content were used as indices of hypertrophy. Reactive R[JHQVSHFLHV 526 ZHUHGHWHFWHGE'+(ÀXRUHVFHQFHVWDLQLQJ HO-1 and STAT3 protein expression were detected by Western blot. Cardiomyocytes apoptosis were assessed by TUNEL assay. RESULTS AND MAJOR FINDINGS: In Type-1 diabetic UDWV PRFDUGLDO ) W LVRSURVWDQH ZDV VLJQL¿FDQWO LQFUHDVHG accompanied with cardiomyocytes hypertrophy and impaired left ventricular function that was coincident with reduced HO-1 activity and STAT3 activation despite of an increase in HO-1 protein H[SUHVVLRQDVFRPSDUHGWRFRQWURO 3URSRIROLQIXVLRQVLJQL¿FDQWO improved cardiac function with concomitantly enhanced HO-1 activity and STAT3 activation. Similar to the changes seen in diabetic rat hearts, high glucose exposure for 48 hours led to cardiomyocytes hypertrophy and apoptosis in both the primarily cultured neonatal rat cardiomyocyte and in H9c2 cells compared to normal glucose, DFFRPSDQLHG E LQFUHDVHG 526 3URSRIRO VLJQL¿FDQWO LQFUHDVHG cardiomyocyte HO-1 and p-STAT3 protein expression and HO-1 activity and attenuated HG-mediated cardiomyocyte hypertrophy and apoptosis and reduced ROS production (P<0.05). These protective effects of propofol were abolished by HO-1 or STAT3 gene knock down in H9c2 cells. CONCLUSIONS: Activation of the HO-1/STAT3 signaling path way is major mechanism whereby Propofol mediates amelioration of hyperglycemia-induced cardiomyocyte hypertrophy and apoptosis and cardiac dysfunction. REFERENCES: 1 Circulation 2010;121:1912-25 2 J. of hepatology 2012;56:359-66) 3 BMC gastroenterology 2011;11:144 | - |
dc.language | eng | en_US |
dc.publisher | Lippincott, Williams & Wilkins. The Journal's web site is located at http://www.anesthesia-analgesia.org | - |
dc.relation.ispartof | Anesthesia and Analgesia | en_US |
dc.rights | This is a non-final version of an article published in final form in Anesthesia and Analgesia, 2014, v. 118 n. 5S, p. S-77 | - |
dc.title | Propofol Ameliorates Hyperglycemia-induced Cardiac Hypertrophy and Dysfunction Via Heme Oxygenase-1 /STAT3 Signaling Pathway in Rats | en_US |
dc.type | Conference_Paper | en_US |
dc.identifier.email | Xu, J: xushiwei@hku.hk | en_US |
dc.identifier.email | Xia, Z: zyxia@hkucc.hku.hk | en_US |
dc.identifier.authority | Xia, Z=rp00532 | en_US |
dc.identifier.hkuros | 235604 | en_US |
dc.identifier.volume | 118 | en_US |
dc.identifier.issue | 5S | - |
dc.identifier.spage | S-77 | en_US |
dc.identifier.epage | S-77 | en_US |
dc.publisher.place | United States | - |
dc.identifier.issnl | 0003-2999 | - |